PATENT CLAIM ANALYSIS

Application Number: 16181088
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "136100"]

Abstract:
The present invention is in the fields of biochemistry, molecular biology, and Alzheimer's disease diagnosis, prevention, and treatment. Provided herein are humanized antibodies against human tau that are capable of discriminating between normal (healthy) and pathological (disease-associated) tau.

Claim (Index 196):
A method of treatment, comprising administering to a subject a therapeutically effective amount of the composition according to  claim 180 .

Metadata:
- Claim Count in Document: 79.0
- Percentile: 98.0
- Lexical Diversity: 1.28947
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15528333', '15342629', '15599685', '15906773', '15207836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582908138210194
- 35 USC 102 Novelty (BERT): 0.6055710766745791
- Combined Prediction Score: 0.7430188401063754
- Mean Citation Score: 506.236552
- Max Citation Score: 786.5726
- Similarity Product: 454.58669495711325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test